Earlier this year, two new laws were enacted that impact patent listings in the Orange Book (drugs) and Purple Book (biologics). The Orange Book Transparency Act primarily codifies current FDA ...

The patents at issue were five patents Teva had listed in the Orange Book for its ProAir® HFA (albuterol sulfate) Inhalation Aerosol. The patents are described in the Federal Circuit opinion as ...

“[I]t appears that the pendulum is swinging back in favor of Orange Book patent owners. The number of petitions challenging these patents has slowed since the high rates seen in the 2015 and 2016 ...

A recent ruling in the U.S. District Court for the District of New Jersey could have far reaching implications on the development and sale of generic drug products. While the judge's decision is ...

The overarching theme of this book is to approach inventing in a business responsible way, so Janessa had me on page 1. Many who are unfamiliar with the trials and tribulations of inventors frequently ...

Patents are interesting things. While they do not directly provide information on guaranteed products which will hit the market in the near (or long term) future, what they do is provide insight to ...

A patent attorney named Daren Gibby was kind enough to send me a copy of his new book Why Has America Stopped Inventing? As you'd expect from a book written by a patent attorney, it's a pretty ...

Google has filed a pair of patents with the USPTO that aim to reinvent how we interact with printed media. The first patent is for an "Interactive Book" with motion and pressure sensors embedded ...